Stuck between Syndromic and Single-Target Testing? Flex Testing May Be the Answer
Josh Griffith
Flex testing allows labs to run full syndromic panels without paying for every result
Josh Griffith
Josh Griffith is vice president of global marketing for Luminex Corporation, which develops, manufactures, and markets biological testing technologies in the clinical diagnostic and life science industries. Over his nearly 10 years at Luminex, he has held multiple marketing and business management roles. Before joining the company, Josh spent eight years in sales management at companies including Roche Diagnostics and Forest Pharmaceuticals. He received his bachelor’s degree from Drew University in Madison, NJ.